Product Code: 4480
The global LASIK eye surgery devices market share is projected to increase substantially over 2022-2030, driven by the strong demand for minimally invasive surgical procedures.
LASIK surgery is being widely considered as a preferred minimally invasive surgery option to correct astigmatism, myopia, hyperopia, and other refractive errors, due to benefits such as faster recovery time, less pain, and reduced costs. With the rapid advancement in minimally invasive tech, the acceptance of corrective eye surgery has increased worldwide, warranting high demand for LASIK eye surgery devices.
The high cost of LASIK surgery devices and their associated maintenance may, however, act as a key restraining factor to industry progression over the forecast period.
The LASIK eye surgery devices industry is segmented in terms of product, end-use, and region.
On the basis of product, the market is divided into excimer and femtosecond laser segments. Of these, the excimer laser segment is slated to witness commendable growth through 2030, driven by its emergence as an effective treatment for a range of corneal disorders.
This type of laser can also treat epithelial instability, corneal surface irregularity, and superficial opacity, leading to high preference from patient populations and in turn driving segmental growth.
In terms of the end-use, the industry is segregated into LASIK eye centers, ambulatory surgical centers, hospitals, and others. The others segment, which includes health centers, clinics, optometrists, and eye research institutes, is projected to register a revenue of over USD 200 million by 2030. This is attributable to the expansion of healthcare chains including clinics and other LASIK treatment services, especially in developing economies.
For instance, in June 2022, Netradeep Eye Hospital merged with Maxivision Group of Eye Hospitals as a part of its plans to provide comprehensive eye care services. Key facilities under the new brand include Advanced Cataract Surgeries, LASIK, Cornea Clinic, and Pediatric Eye Care. Initiatives such as these are expected to escalate the use of LASIK eye surgery equipment in clinics and other healthcare facilities.
From a regional perspective, the Asia Pacific held more than 25% of the LASIK eye surgery devices industry share in 2021. This can be credited to the growing incidence of myopia, predominantly in high-income APAC countries.
The requirement for refractive surgery devices in the region is further influenced by lifestyle and environmental variables including aging, air pollution, and surging screen time, which are creating a strong outlook for the regional market.
Meanwhile, the Middle East and Africa (MEA) LASIK eye surgery devices market recorded a revenue of nearly USD 70 million in 2021, given the increasing healthcare expenditure, availability of cost-effective LASIK procedures, and favorable government healthcare schemes.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definitions
- 1.2 Base estimates & working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Public sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 LASIK eye surgery devices industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 End-use trends
- 2.1.4 Regional trends
Chapter 3 LASIK Eye Surgery Devices Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Technological advancements in developed countries
- 3.3.1.2 Increasing number of people suffering from ophthalmic disorders
- 3.3.1.3 Increasing eye care expenditure
- 3.3.1.4 Increasing demand for minimally invasive surgical procedures
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 High cost of ophthalmic devices
- 3.3.2.2 Risk associated with eye surgeries
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By end-use
- 3.5 COVID- 19 impact analysis
- 3.6 Porter's analysis
- 3.7 Competitive landscape, 2021
- 3.7.1 Company matrix analysis, 2021
- 3.8 PESTEL analysis
Chapter 4 LASIK Eye Surgery Devices Market, By Product
- 4.1 Key segment trends
- 4.2 Excimer laser
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Femtosecond laser
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 LASIK Eye Surgery Devices Market, By End-use
- 5.1 Key segment trends
- 5.2 LASIK eye centers
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Hospitals
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.4 Ambulatory surgical centers
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.5 Others
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 LASIK Eye Surgery Devices Market, By Region
- 6.1 Key regional trends
- 6.2 North America
- 6.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 6.2.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.2.4 U.S.
- 6.2.4.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.2.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.2.5 Canada
- 6.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.2.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3 Europe
- 6.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 6.3.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.4 Germany
- 6.3.4.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.3.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.5 UK
- 6.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.3.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.6 France
- 6.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.3.6.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.7 Italy
- 6.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.3.7.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.3.8 Spain
- 6.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.3.8.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4 Asia Pacific
- 6.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 6.4.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4.4 China
- 6.4.4.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.4.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4.5 Japan
- 6.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.4.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4.6 India
- 6.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.4.6.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.4.7 Australia
- 6.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.4.7.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.5 Latin America
- 6.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.5.4 Brazil
- 6.5.4.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.5.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.5.5 Mexico
- 6.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.5.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.6 MEA
- 6.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 6.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.6.4 South Africa
- 6.6.4.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.6.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
- 6.6.5 GCC countries
- 6.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 6.6.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 7 Company Profiles
- 7.1 Strategy dashboard, 2021
- 7.2 Alcon, Inc.
- 7.2.1 Business overview
- 7.2.2 Financial data
- 7.2.3 Product landscape
- 7.2.4 Strategic outlook
- 7.2.5 SWOT analysis
- 7.3 Bausch & Lomb Incorporated (Bausch Health)
- 7.3.1 Business overview
- 7.3.2 Financial data
- 7.3.3 Product landscape
- 7.3.4 SWOT analysis
- 7.4 Carl Zeiss Meditec AG
- 7.4.1 Business overview
- 7.4.2 Financial data
- 7.4.3 Product landscape
- 7.4.4 SWOT analysis
- 7.5 Johnson & Johnson
- 7.5.1 Business overview
- 7.5.2 Financial data
- 7.5.3 Product landscape
- 7.5.4 Strategic outlook
- 7.5.5 SWOT analysis
- 7.6 iVIS Technologies
- 7.6.1 Business overview
- 7.6.2 Financial data
- 7.6.3 Product landscape
- 7.6.4 SWOT analysis
- 7.7 NIDEK CO., LTD.
- 7.7.1 Business overview
- 7.7.2 Financial data
- 7.7.3 Product landscape
- 7.7.4 Strategic outlook
- 7.7.5 SWOT analysis
- 7.8 SCHWIND eye-tech-solutions
- 7.8.1 Business overview
- 7.8.2 Financial data
- 7.8.3 Product landscape
- 7.8.4 Strategic outlook
- 7.8.5 SWOT analysis
- 7.9 TECHNOLAS PERFECT VISION GMBH
- 7.9.1 Business overview
- 7.9.2 Financial data
- 7.9.3 Product landscape
- 7.9.4 SWOT analysis
- 7.10 Ziemer Ophthalmic Systems
- 7.10.1 Business overview
- 7.10.2 Financial data
- 7.10.3 Product landscape
- 7.10.4 Strategic outlook
- 7.10.5 SWOT analysis